Company Search:
Advanced Search
Sponsored Links
argenx SE Company Snapshot
argenx SE operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares argenx SE with three other miscellaneous service companies in Europe: GW Pharmaceuticals PLC of the United Kingdom (2018 sales of £20.00 million [US$26.05 million] of which 100% was Novel Therapeutics), MDxHealth S.A. (24.10 million Euro [US$26.17 million] of which 100% was Diagnostic Tools), and Oncodesign Sa which is based in France (20.09 million Euro [US$21.81 million] ).

Sales Analysis. argenx SE reported sales of 21.48 million Euro (US$23.32 million) for the year ending December of 2018. This represents a sharp decrease of 41.0% versus 2017, when the company's sales were 36.42 million Euro. Contributing to the drop in overall sales was the 78.7% decline in Research and Development Service Fees (F, from 6.60 million Euro to 1.41 million Euro. There were also decreases in sales in Upfront Payments (down 57.1% to 8.64 million Euro) . However, these declines were partially offset by the increase in sales of Milestone Payments (up 18.2% to 11.44 million Euro) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
argenx SE
  Stock Performance Chart for argenx SE
  Stock Data: Recent Stock Performance:
  Current Price (2/14/2020): 149.30
(Figures in Euro)
1 Week 6.1%   13 Weeks 7.9%  
4 Weeks 19.0%   52 Weeks 40.1%  
argenx SE Key Data:
  Ticker: ARGX Country: Netherlands
  Exchanges: BRU Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 21,482,000
(Year Ending Jan 2019).
Employees: 105
  Currency: Euro Market Cap: 5,689,453,781
  Fiscal Yr Ends: December Shares Outstanding: 38,107,527
  Share Type: Actions Ordinaires Closely Held Shares:
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.